 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Molbio Diagnostics Limited |
| Street 1: | Plot No. L-46 , Phase II D, |
| Street 2: | Verna Industrial Estate |
| City: | Verna , Goa |
| Province: | |
| Post Code: | 403722 |
| Country: | India |
| Phone: | +918326724888 |
| Organization Email: | vianca@molbiodiagnostics.com |
| Web Site: | http://www.molbiodiagnostics.com/ |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 30AACCM8275E1ZO |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-care diagnostics. With a vision focused on universalizing access to precise, rapid and cost-effective healthcare technologies, Molbio is at the forefront of providing cutting-edge solutions for quality healthcare delivery at the last mile by decentralizing and democratizing diagnostics through its advanced portable platforms. Renowned for its WHO-endorsed Truenat® real-time PCR platform, and an ever-growing basket of tests, Molbio empowers remote, resource-poor settings worldwide to implement sophisticated diagnostics for infectious diseases like TB and hepatitis to non-communicable diseases such as breast cancer, sickle cell disease, and more. | |
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Civil Society and Community Engagement Delivery of health services and care Engaging political leaders and ensuring inclusive leadership Provision of drugs, diagnostics and commodities Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 100 + |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | India |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| ICMR, after extensive validations has found Truenat to be a more sensitive and specific test and hence recommended it as a replacement to smear microscopy for diagnosis of TB and Rifampicin resistance under the RNTCP algorithm. Ministry of Health has now initiated roll-out of the test across India, with Andhra Pradesh being the first state to use Truenat as a frontline tool for TB detection at Primary Health Centre level. With this intervention, the state is seeing a substantial increase in case detection. | |
Geographical Reach | |
| Which country is your headquarters located in: | India |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Algeria Bangladesh Bolivia Botswana Brazil Burkina Faso Cambodia Cameroon Central African Republic Democratic Republic of the Congo Democratic Republic of Timor-Leste Ethiopia Gabon Gambia Germany Ghana Guatemala India Indonesia Iraq Israel Kenya Mexico Mozambique Myanmar Nepal Netherlands Nigeria Peru Philippines South Africa Switzerland Turkey Uganda United Kingdom of Great Britain and Northern Ireland Viet Nam Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Microchip available for Truenat® MTB, Truenat® MTB-RIF Dx, Truenat® MTB-INH Laboratory Strengthening: ICMR, after extensive validations has found Truenat to be a more sensitive and specific test and hence recommended it as a replacement to smear microscopy for diagnosis of TB and Rifampicin resistance under the RNTCP algorithm. Ministry of Health has now initiated roll-out of the test across India, with Andhra Pradesh being the first state to use Truenat as a frontline tool for TB detection at Primary Health Centre level. With this intervention, the state is seeing a substantial increase in case detection. New Diagnostics: Molbio offers a 'global first' platform that can perform Molecular Diagnostics for infectious diseases at the point-of-care - Truelab Real Time Quantitative micro PCR System. This compact battery-operated system has single testing capability and provides sample to result within 1 hour. Hence, it enables same day reporting and initiation of evidence-based treatment for the patient. It also has real-time data transfer capability (through SMS/E-mail/data push) for immediate reporting of results in emergency cases. |
|
Declaration | |
| Declaration of interests: No conflict | |
| Application date: | June 8, 2023 |
| Last updated: | April 2, 2025 |